Home  

Enter a class name or drug name above to search the database.

Genitourinary Arterial Vasodilation [PE]

NDC Number Brand Name Generic Name Labeler Dosage Form DEA Schedule Marketing Start Date
0009-0215 PROSTIN VR PEDIATRIC alprostadil Pharmacia & Upjohn Company LLC INJECTION, SOLUTION 2022-10-03
0009-3169 PROSTIN VR PEDIATRIC alprostadil Pharmacia and Upjohn Company LLC INJECTION, SOLUTION 1981-10-16
0009-3701 Caverject Alprostadil Pharmacia & Upjohn Company LLC INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 1995-07-06
0009-5181 Caverject Impulse Alprostadil Pharmacia & Upjohn Company LLC INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2002-06-11
0009-5182 Caverject Impulse Alprostadil Pharmacia & Upjohn Company LLC INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2002-06-11
0009-7686 Caverject Alprostadil Pharmacia & Upjohn Company LLC INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 1995-07-06
52244-010 Edex alprostadil ENDO USA, Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2012-04-15
52244-020 Edex alprostadil ENDO USA, Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2012-01-15
52244-040 Edex alprostadil ENDO USA, Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2012-03-15
63539-121 Caverject Impulse Alprostadil U.S. Pharmaceuticals INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2014-05-04
63539-221 Caverject Impulse Alprostadil U.S. Pharmaceuticals INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2014-05-04
71288-206 Alprostadil Alprostadil Meitheal Pharmaceuticals Inc. INJECTION, SOLUTION, CONCENTRATE 2024-09-15

 Physiological Effect (PE) Classification 

Loading full table content...